Molecule Name |
DB00238
|
DrugBank Groups |
Approved
|
Cluster No |
102
|
Smiles |
O=C2(NC1(=C(N=CC=C1C)N(C3(=C2C=CC=N3))C4(CC4)))
|
Download |
mol2, pdbqt
|
TPSA |
58,12
|
Non-H Atoms |
20
|
Non-C/H Atoms |
5
|
Metal-Atoms |
0
|
Electronegative Atoms |
5
|
Stereo Centers |
0
|
Rotatable Bonds |
1
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
2
|
Aromatic Atoms |
12
|
sp3-Atoms |
5
|
Symmetric atoms |
1
|
cLogS |
-4,666
|
MW |
266,303
|
cLogP |
1,9589
|
HBA |
5
|
HBD |
1
|
Ro5 violations |
0
|
Druglikeness |
2,0996
|
DrugScore |
0,710253747968234
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,2527
|
Caco-2 Permeability 2 |
1,3542
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,7883
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,4312
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
II
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6729
|
Carcinogenicity (Three-class) |
Non-required
|